Compare Gema Grahasarana Tbk. (GEMA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gema Grahasarana Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Gema Grahasarana Tbk. trades at Rp93 (market cap 148.8B, 3.37M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Gema Grahasarana Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| GEMA | SCPI | |
|---|---|---|
Market Cap | 148.8B | 104.4B |
Volume | 3.37M | — |
Lot | 33.71K | — |
Turnover | 308.17M | — |
Average Price | 91.43 | — |
Value | 308.17M | — |
Indicative Equilibrium Price | 93 | — |
Indicative Equilibrium Volume | 2 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gema Grahasarana Tbk.
PT Gema Grahasarana Tbk formerly PT Gema Gerhana Sarana (The Company) was established on December 7th 1984 in Jakarta. The corporate is a member of Vinoti business. The core business is in manufacture, trade and services of interior & furniture. Corporate have 2 subsidiaries: 1. LKS which conduct in industry, trade & service of panel component of furniture & interior. 2. PGM which conduct in industry, trade & construction service of mechanical, electrical for industrial, commercial & industrial.
Read more on GEMA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
